within Pharmacolibrary.Drugs.ATC.M;

model M02AA19
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 3.3333333333333335e-07,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00011999999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.007166666666666667,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.00015,
    k12             = 0.086,
    k21             = 0.086
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M02AA19</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) belonging to the phenylalkanoic acid derivative class, known for its analgesic, anti-inflammatory, and antipyretic activities. It is primarily used for the symptomatic treatment of pain and inflammation in musculoskeletal disorders and is available in both oral and topical formulations. Flurbiprofen is approved and used in several countries for pain management.</p><h4>Pharmacokinetics</h4><p>PK parameters reported in healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Kaiser, DG, et al., &amp; Lomen, PL (1986). Pharmacokinetics of flurbiprofen. <i>The American journal of medicine</i> 80(3A) 10–15. DOI:<a href=&quot;https://doi.org/10.1016/0002-9343(86)90104-x&quot;>10.1016/0002-9343(86)90104-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3963013/&quot;>https://pubmed.ncbi.nlm.nih.gov/3963013</a></p></li><li><p>Davies, NM (1995). Clinical pharmacokinetics of flurbiprofen and its enantiomers. <i>Clinical pharmacokinetics</i> 28(2) 100–114. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199528020-00002&quot;>10.2165/00003088-199528020-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7736686/&quot;>https://pubmed.ncbi.nlm.nih.gov/7736686</a></p></li><li><p>Suri, A, et al., &amp; Derendorf, H (1997). Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration. <i>International journal of clinical pharmacology and therapeutics</i> 35(1) 1–8. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9021434/&quot;>https://pubmed.ncbi.nlm.nih.gov/9021434</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M02AA19;
